Incorporating the Time Dimension in Receiver Operating Characteristic Curves: A Case Study of Prostate Cancer
暂无分享,去创建一个
Gary Longton | Ruth Etzioni | Margaret Pepe | Gary Goodman | Ruth Etzioni | M. Pepe | G. Longton | G. Goodman | Chengcheng Hu
[1] D. Bates,et al. Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .
[2] H. Carter,et al. Mixed-effects regression models for studying the natural history of prostate disease. , 1994, Statistics in medicine.
[3] A S Whittemore,et al. Prostate-specific antigen as predictor of prostate cancer in black men and white men. , 1995, Journal of the National Cancer Institute.
[4] Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). , 1993, Controlled clinical trials.
[5] M. Benson,et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.
[6] C G Chute,et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.
[7] C B Begg,et al. A General Regression Methodology for ROC Curve Estimation , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] H. Klocker,et al. Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels , 1997, The Prostate.
[9] Jerome P. Richie,et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.
[10] Margaret S. Pepe,et al. A regression modelling framework for receiver operating characteristic curves in medical diagnostic testing , 1997 .
[11] E. Metter,et al. Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. , 1996, Urology.
[12] M S Pepe,et al. Three approaches to regression analysis of receiver operating characteristic curves for continuous test results. , 1998, Biometrics.
[13] A W Partin,et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.